Why scientists can now modify DNA
With a few easy tweaks, scientists can cut-and-paste DNA inside living cells, thanks to a promising new technique that could make possible everything from testing new drugs or curing genetic diseases.
And researchers just discovered a way to make the process a whole lot cheaper and easier, according to a study published Thursday in the journal Developmental Cell.
For less than $100, the new process allows scientists to make some of the key materials needed to modify an organism’s entire genome, or it’s complete set of DNA, the researchers said.
The advance is based on a technique that allows scientists to narrow in on a specific gene and cut-and-paste bits of DNA to change its function, known as CRISPR-Cas9. Jennifer Doudna at UC Berkeley and her colleagues first discovered this natural process that bacteria use to protect themselves against invading viruses.
But the technique is much more powerful than that — it basically gives scientists the ability to rewrite specific chunks of an organism’s genetic code, including that of humans.
Tweaking our genes
Here’s how it works: When a bacterium encounters DNA from a virus, it makes a strand of RNA, a molecular cousin to DNA, that matches the sequence of the viral DNA, known as a guide RNA. The guide RNA latches onto a protein (the Cas9 part of the CRISPR-Cas9 name), and together they search for the matching virus. When they find a match, the protein, which acts like a pair of scissors, cuts up the viral DNA, destroying it.
The same process can be used to cut-and-paste DNA into virtually any type of living cell. For example, instead of using the protein scissors to cut a virus, they can be used to cut out DNA in a human cell and replace it with DNA of the scientist’s choosing.
In this way, it would be possible to swap out a defective version of a gene for a healthy one.
Humans have roughly 20,000 to 25,000 genes, which encode proteins that perform vital jobs in our cells. But our genetic blueprint has a lot of other DNA whose purpose is less obvious. The successor to the human genome project, the Encyclopedia of DNA Elements (ENCODE), has identified what 80% of our complete set of DNA does, but the rest remains a mystery.
In the new study, the researchers developed a method that makes it easier to create the guide molecules that home in on the DNA someone wants to tweak. The researchers hilariously named the process “CRISPR-EATING,” which stands for “Everything Available Turned Into New Guides.”
To demonstrate the technique, the researchers converted nearly 90% of the DNA of the common stomach bacterium E. coli (the harmless variety, not the kind that can make you sick) into 40,000 different guide molecules. Each of these molecules can be used to target any bit of DNA a researcher might want to modify.
For example, if a scientist wants to figure out what a particular gene does, all he or she has to do is cut it out and see what happens. Thousands of these guides can be injected into different cells at once, a process known as genetic screening. These screens can reveal which forms of a gene are present, and whether any of them could lead to disease.
Monitoring a growing embryo
But the researchers who developed this technology have a different use in mind. They plan to track chromosomes, the tightly coiled packages of DNA that contain the genes, in living cells as the cells are dividing. They’re hoping to find out what controls the size of the nucleus, the central compartment of a cell that contains the DNA, and other components of the cell as it develops into a many-celled organism.
“This technology will allow us to paint a whole chromosome and look at it live and really follow it … as it goes through developmental transitions, for example in an embryo,” study co-author Rebecca Heald, a molecular and cell biologist at UC Berkeley, said in a statement.
This is important because it means researchers can track changes in the size and structure of chromosomes as the cells divide — and potentially detect changes that could lead to disease.
Earlier this year, Chinese scientists caused a controversy when they announced they’d used the gene editing technique to tweak the genomes of human embryos. The embryos were chosen because they weren’t able to survive, but some scientists have warned about the ethics and safety of using this nascent technology in people.
One concern is the fact that the technique is still fairly innacurate, and results in a lot of accidental mutations in other parts of the genome. Of the 86 embryos the Chinese researchers attempted to modify, only 28 of them were successfully changed, and only a fraction of those contained the desired DNA. For the technique to be safe, the accuracy would have to be closer to 100%, the researchers said.
Recently, scientists developed a way to cut down on unwanted mutations by 40%, which could make the technique a lot safer for human use. But the ethical hurdles remain.
This article is published in collaboration with Business Insider. Publication does not imply endorsement of views by the World Economic Forum.
To keep up with the Agenda subscribe to our weekly newsletter.
Author: Tanya Lewis is a science reporter at Business Insider, specializing in the intersection between biology and tech.
Image: Molecular Genetics Technical Specialist Jaime Wendt looks at a slide containing DNA at the Human and Molecular Genetics Center Sequencing Core at the Medical College of Wisconsin in Milwaukee, Wisconsin, May 9, 2014. REUTERS/Jim Young
Don't miss any update on this topic
Create a free account and access your personalized content collection with our latest publications and analyses.
License and Republishing
World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.
The views expressed in this article are those of the author alone and not the World Economic Forum.
Stay up to date:
Emerging Technologies
Forum Stories newsletter
Bringing you weekly curated insights and analysis on the global issues that matter.
More on Emerging TechnologiesSee all
Michele Mosca and Donna Dodson
December 20, 2024